Showing results (1-10 of 379) with videos related to
Sort By:
Pageof 38
Hematology. American Society of Hematology. Education Program|November 24, 2005
Management of polycythemia vera and essential thrombocythemiaPeter J Campbell, Anthony R GreenHaematologica|June 11, 2010
Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenasePhilip A Beer, Peter J Campbell, Anthony R GreenBlood|June 15, 2006
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemiaLinda M Scott, Mike A Scott, Peter J Campbell, et al.Blood|November 26, 2010
How I treat essential thrombocythemiaPhilip A Beer, Wendy N Erber, Peter J Campbell, et al.Haematologica|May 2, 2013
Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemiaAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.Methods in Molecular Medicine|March 1, 2006
Methods for the detection of the JAK2 V617F mutation in human myeloproliferative disordersPeter J Campbell, Linda M Scott, E Joanna Baxter, et al.Haematologica|July 5, 2006
Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemiaNasios Fourouclas, Peter J Campbell, Anthony J Bench, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapyPeter J Campbell, David Bareford, Wendy N Erber, et al.Blood|June 20, 2012
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortPeter J Campbell, Cathy MacLean, Philip A Beer, et al.Blood|December 8, 2017
Myeloproliferative neoplasms: from origins to outcomesJyoti Nangalia, Anthony R GreenPageof 38